Vimarsana
Biggest News Aggregation in the World

Ruth Karron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ruth Karron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ruth Karron Today - Breaking & Trending Today

STAT to host three-day, virtual 'Future Summit' September 5-7 - Vimarsana News

STAT to host three-day, virtual 'Future Summit' September 5-7

/PRNewswire/ -- STAT, the leading media company reporting on health, science, and medicine, is proud to host its inaugural STAT Future Summit next week, Sept....

New RSV Shot Is a Monoclonal Antibody, Not a Vaccine - Vimarsana News

New RSV Shot Is a Monoclonal Antibody, Not a Vaccine

A monoclonal antibody will be offered this fall to prevent respiratory syncytial virus in children. If antibodies are a viable vaccine alternative for kids, will we see new options for adults too?

We'll soon have tools to curb RSV. Can we put them to good use? - Vimarsana News

We'll soon have tools to curb RSV. Can we put them to good use?

There are sizable hurdles standing in the way of the implementation of both a new vaccine and a monoclonal antibody.

FDA approves first RSV vaccine, Arexvy, for adults 60 and over, a moment six decades in the making - Vimarsana News

FDA approves first RSV vaccine, Arexvy, for adults 60 and over, a moment six decades in the making

The FDA approved the first RSV vaccine Wednesday, called Arexvy, which is designed to be given as a single shot to adults 60 and over.

Source: abc11.com
'A Wonderful Development': FDA Approves Vaccine 60 Years In The Making - Vimarsana News

'A Wonderful Development': FDA Approves Vaccine 60 Years In The Making

The FDA has approved the first-ever vaccine designed to protect against respiratory syncytial virus (RSV), a development 60 years in the making.